[35S]GTPγS binding at the human dopamine D4 receptor variants hD4.2, hD4.4 and hD4.7 following stimulation by dopamine, epinephrine and norepinephrine

European Journal of Pharmacology

Volumn 531, Issue 1-3, 2006, Pages 20-24

  Czermak, Christoph ^a,b   Lehofer, Michael ^a   Liebmann, Peter M ^b   Traynor, John ^c  

^a Sigmund Freud Clinics   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

35S GTP S; Dopamine D4 receptor; Epinephrine; Norepinephrine; Polymorphism; Sodium

Indexed keywords

ADRENALIN HYDROGEN TARTRATE; DOPAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE 4.2 RECEPTOR; DOPAMINE 4.4 RECEPTOR; DOPAMINE 4.7 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); NORADRENALIN BITARTRATE; SODIUM; SULFUR 35; UNCLASSIFIED DRUG; ADRENALIN; CATECHOLAMINE; NORADRENALIN; SODIUM CHLORIDE; SULFUR;

AGONIST; ANIMAL CELL; ARTICLE; ASSAY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; RECEPTOR SENSITIVITY; ANIMAL; BINDING COMPETITION; CELL MEMBRANE; CHO CELL; COMPARATIVE STUDY; CRICETULUS; DOSE RESPONSE; DRUG EFFECT; GENETICS; HAMSTER; HUMAN; METABOLISM;

ANIMALS; BINDING, COMPETITIVE; CATECHOLAMINES; CELL MEMBRANE; CHO CELLS; CRICETINAE; CRICETULUS; DOPAMINE; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; NOREPINEPHRINE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D4; SODIUM CHLORIDE; SULFUR RADIOISOTOPES;

EID: 32044473260     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.11.063     Document Type: Article

References (19)

1. V. Asghari, O. Schoots, S. van Kats, K. Ohara, V. Jovanovic, H.C. Guan, J.R. Bunzow, A. Petronis, and H.H. Van Tol Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes Mol. Pharmacol. 46 1994 364 373
2. V. Asghari, S. Sanyal, S. Buchwaldt, A. Paterson, V. Jovanovic, and H.H. Van Tol Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants J. Neurochem. 65 1995 1157 1165
3. F.M. Chang, J.R. Kidd, K.J. Livak, A.J. Pakstis, and K.K. Kidd The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus Hum. Genet. 98 1996 91 101
4. Y.C. Ding, H.C. Chi, D.L. Grady, A. Morishima, J.R. Kidd, K.K. Kidd, P. Flodman, M.A. Spence, S. Schuck, J.M. Swanson, Y.P. Zhang, and R.K. Moyzis Evidence of positive selection acting at the human dopamine receptor D4 gene locus Proc. Natl. Acad. Sci. U. S. A. 99 2002 309 314
5. 35S]GTPγS binding assay: approaches and applications in pharmacology Life Sci. 74 2003 489 508
6. D.A. Horstman, S. Brandon, A.L. Wilson, C.A. Guyer, E.J. Cragoe Jr., and L.E. Limbird An aspartate conserved among G-protein receptors confers allosteric regulation of alpha 2-adrenergic receptors by sodium J. Biol. Chem. 265 1990 21590 21595
7. V. Jovanovic, H.C. Guan, and H.H. Van Tol Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants Pharmacogenetics 9 1999 561 568
8. F. Lanau, M.T. Zenner, O. Civelli, and D.S. Hartman Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor J. Neurochem. 68 1997 804 812
9. R.J. Lefkowitz, S. Cotecchia, P. Samama, and T. Costa Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins Trends Pharmacol. Sci. 14 1993 303 307
10. J.B. Lichter, C.L. Barr, J.L. Kennedy, H.H. Van Tol, K.K. Kidd, and K.J. Livak A hypervariable segment in the human dopamine receptor D4 (DRD4) gene Hum. Mol. Genet. 2 1993 767 773
11. J.M. Lusher, C. Chandler, and D. Ball Dopamine D4 receptor gene (DRD4) is associated with Novelty Seeking (NS) and substance abuse: the saga continues... Mol. Psychiatry 6 2001 497 499
12. A. Newman-Tancredi, V. Audinot-Bouchez, A. Gobert, and M.J. Millan Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors Eur. J. Pharmacol. 319 1997 379 383
13. J.N. Oak, J. Oldenhof, and H.H. Van Tol The dopamine D(4) receptor: one decade of research Eur. J. Pharmacol. 405 2000 303 327
14. J. Oldenhof, R. Vickery, M. Anafi, J. Oak, A. Ray, O. Schoots, T. Pawson, M. von Zastrow, and H.H. Van Tol SH3 binding domains in the dopamine D4 receptor Biochemistry 37 1998 15726 15736
15. O. Schoots, and H.H. Van Tol The human dopamine D4 receptor repeat sequences modulate expression Pharmacogenomics J. 3 2003 343 348
16. K. Van Craenenbroeck, S.D. Clark, M.J. Cox, J.N. Oak, F. Liu, and H.H. Van Tol Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis J. Biol. Chem. 280 2005 19350 19357
17. H.H. Van Tol, C.M. Wu, H.C. Guan, K. Ohara, J.R. Bunzow, O. Civelli, J. Kennedy, P. Seeman, H.B. Niznik, and V. Jovanovic Multiple dopamine D4 receptor variants in the human population Nature 358 1992 149 152
18. E. Wang, Y.C. Ding, P. Flodman, J.R. Kidd, K.K. Kidd, D.L. Grady, O.A. Ryder, M.A. Spence, J.M. Swanson, and R.K. Moyzis The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus Am. J. Hum. Genet. 74 2004 931 944
19. M.G. Ziegler, X. Bao, B.P. Kennedy, A. Joyner, and R. Enns Location, development, control, and function of extraadrenal phenylethanolamine N-methyltransferase Ann. N. Y. Acad. Sci. 971 2002 76 82